Board Meetings for ASTRAZEN
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| ASTRAZEN | AstraZeneca Pharma India Limited | 30 May 2014 | Results/Dividend | for considering Audited Financial Results of the Company, for the last quarter and financial year ended March 31, 2014 & may also consider 'recommendation of dividend' for the financial year ended March 31, 2014. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 05 May 2014 | Delisting | To consider inter-alia seeking approval of shareholders of the Company through Postal Ballot, for the voluntary delisting proposed by AstraZeneca Pharmaceuticals AB Sweden, Promoter of the Company, in terms of Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 15 Apr 2014 | Meeting Updates | to consider inter-alia, seeking approval of shareholders of the Company through Postal Ballot, for the voluntary delisting proposed by AstraZeneca Pharmaceuticals AB Sweden, Promoter of the Company, in terms of Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 15 Mar 2014 | Voluntary Delisting | With reference to the earlier announcement dated March 05, 2014 regarding the Outcome of the Board Meeting held on March 05, 2014, the company has now informed Exchange that the voluntary delisting proposal from AstraZeneca Pharmaceuticals AB, Sweden (AZP AB) in terms of their letter dated March 01, 2014 will be considered at the meeting of the Board of Directors of the Company to be held on March 15, 2014. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 05 Mar 2014 | Delisting | To consider the Delisting Proposal and Matters incidental hereto. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 10 Feb 2014 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2013. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 11 Nov 2013 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2013. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 13 Aug 2013 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2013. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 21 May 2013 | Results | Inter alia, to consider and approve the Audited Financial Results of the Company, for the last quarter and financial year ended March 31, 2013. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 21 May 2013 | Results/Dividend | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on May 21, 2013 inter alia, to consider and approve the Audited Financial Results of the Company, for the last quarter and financial year ended March 31, 2013. The Company has now informed the Exchange that the Board of Directors at the aforesaid meeting, may also inter-alia consider 'recommendation of dividend' for the financial year ended March 31, 2013. (Purpose Revised) | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 06 May 2013 | Others | To consider the 'Strategy Plan' for the Company. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 06 Feb 2013 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2012. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 07 Nov 2012 | Un-audited Financial Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2012. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 10 Aug 2012 | Un-audited Financial Results | Inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2012. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 11 May 2012 | Un-audited Financial Results | Inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended March 31, 2012. | - |